Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cushing Syndrome × Osilodrostat × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Adrenal Hyperplasia, Congenital 2 ACTH Syndrome, Ectopic 2 Hypertension 1 Cushing Syndrome 1

Interventions

Metyrapone 2 Perceived Stress Scale 1 Osilodrostat 1 Continuous Glucose Monitoring 1 Adrenalectomy 1 Abiraterone Acetate 1 4-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07104812 2026-02-11

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Mayo Clinic

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Cushing Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡